Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab - an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis

X. Su,Mario E. Lacouture,Yuxia Jia,Sau Lan Wu

Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab - an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis

2009

X. Su
Mario E. Lacouture
Yuxia Jia
Sau Lan Wu

Background: Cetuximab, a chimeric antibody against epidermal growth factor receptor has emerged as an effective therapy for advanced colorectal cancer (CRC) and head-neck cancer. Ho

Keywords:

Pathology
Rash
Cetuximab
Immunology
Skin cancer
Antibody
Epidermal growth factor receptor
Cancer
Colorectal cancer
Medicine
Growth factor receptor
Monoclonal

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations